Clomipramine Gel

Clomipramine Gel
Usage
Clomipramine gel is a compounded topical formulation of a tricyclic antidepressant (TCA) used for localised neuropathic pain and sensory disorders. While clomipramine is typically administered orally for psychiatric conditions, topical formulations may be used for targeted therapy with reduced systemic exposure.
It may be prescribed for:
• Neuropathic pain (e.g., peripheral neuropathy, post-herpetic neuralgia)
• Chronic localised pain syndromes
• Pruritus (itching) associated with nerve-related conditions
• Other practitioner-directed uses where topical neuromodulation is beneficial
Use should be under the supervision of a qualified healthcare professional.

Dosage
Dosage and frequency of application should be determined by the prescribing practitioner based on the condition and response to treatment.
Typical dosing considerations include:
• Apply a thin layer to the affected area once or twice daily, or as directed
• Use the minimum amount necessary to achieve symptom relief
• Apply to clean, dry, intact skin
• Wash hands after application unless the hands are the treatment site
Patients should follow the instructions provided by their healthcare provider.

Mechanisms of Action
Clomipramine is a tricyclic antidepressant (TCA) with neuromodulatory properties.
Its mechanisms include:
Inhibition of serotonin and norepinephrine reuptake
Clomipramine increases levels of these neurotransmitters, which may help modulate pain pathways.
Peripheral neuromodulation
When applied topically, clomipramine may reduce local nerve sensitivity and abnormal pain signalling.
Antipruritic effects
Modulation of neurotransmitters may help reduce itching associated with nerve-related conditions.
Topical use aims to provide local therapeutic effects with minimal systemic absorption.

Contraindications
Clomipramine gel should not be used in patients with:
• Hypersensitivity to clomipramine or other tricyclic antidepressants
• Known allergy to any component of the formulation

Precautions
Clomipramine gel should be used with caution in patients with:
• Broken or damaged skin, which may increase systemic absorption
• Cardiovascular conditions, if significant systemic absorption occurs
• Concurrent use of other serotonergic or antidepressant medications
Additional considerations include:
• Avoid application to large surface areas to minimise systemic exposure
• Possible local side effects include skin irritation, redness, or itching
• Rare systemic effects (e.g., drowsiness, dizziness) may occur if absorption is significant
• Patients should report symptoms such as palpitations, confusion, or excessive drowsiness

Storage
• Store below 25°C unless otherwise directed
• Keep the container tightly closed when not in use
• Protect from heat, moisture, and direct light
• Do not freeze unless specifically instructed
• Keep out of reach of children and pets
Patients should follow the storage instructions provided on the dispensing label supplied by the pharmacy.